AAAAAA

   
Results: 1-15 |
Results: 15

Authors: BOLWELL B GOORMASTIC M DANNLEY R ANDRESEN S OVERMOYER B MENDEZ Z KALAYCIOGLU M DEMARS D WISE K POHLMAN B
Citation: B. Bolwell et al., G-CSF POST-AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION - A RANDOMIZED STUDY OF 5, 10, AND 16 MU-G KG/DAY/, Bone marrow transplantation, 19(3), 1997, pp. 215-219

Authors: WALLER CF MARAN A PARANJAPE JM LI GY XIAO W ZHANG K KALAYCIOGLU M TORRENCE PF SILVERMAN RH
Citation: Cf. Waller et al., SPECIFIC DEGRADATION OF BCR ABL MESSENGER-RNA AND GROWTH SUPPRESSION OF CML CELLS BY 2-5A ANTISENSE OLIGONUCLEOTIDES/, Blood, 90(10), 1997, pp. 4020-4020

Authors: TBAKHI A SREENAN JJ PETTAY JD KALAYCIOGLU M HOELTGE G MILLER ML TUBBS RR
Citation: A. Tbakhi et al., A COMPARATIVE-ANALYSIS OF INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION (FISH) AND REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION (RT-PCR)FOR THE DETECTION OF THE BER ABL FUSION GENE IN CHRONIC MYELOGENOUS LEUKEMIA (CML) AND RELATED DISORDERS/, Laboratory investigation, 74(1), 1996, pp. 720-720

Authors: KALAYCIOGLU M COPELAN E AVALOS B KLEIN J GOORMASTIC M BOLWELL B
Citation: M. Kalaycioglu et al., SURVIVAL AFTER ABO-INCOMPATIBLE ALLOGENEIC BONE-MARROW TRANSPLANT AFTER A PREPARATIVE REGIMEN OF BUSULFAN AND CYCLOPHOSPHAMIDE, Bone marrow transplantation, 15(1), 1995, pp. 105-110

Authors: KALAYCIOGLU M KAVURU M TUASON L BOLWELL B
Citation: M. Kalaycioglu et al., EMPIRIC PREDNISONE THERAPY FOR PULMONARY TOXIC REACTION AFTER HIGH-DOSE CHEMOTHERAPY CONTAINING CARMUSTINE (BCNU), Chest, 107(2), 1995, pp. 482-487

Authors: SHARMA S ZUCCARO K KALAYCIOGLU M ANDRESEN S LICHTIN A POHLMAN B LONG T HUSSEIN MA
Citation: S. Sharma et al., PRE-MEDICATION (PM) FOR PLATELET (PLT) TRANSFUSION (TX) - A PROSPECTIVE-STUDY ON THE EFFICACY OF 4 COMMONLY USED REGIMENS, Blood, 86(10), 1995, pp. 1402-1402

Authors: BOLWELL B GOORMASTIC M DANNLEY R ANDRESEN S OVERMOYER B POHLMAN B MENDEZ Z KALAYCIOGLU M DEMARS D WISE K
Citation: B. Bolwell et al., G-CSF POST-AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) TRANSPLANT - A RANDOMIZED STUDY OF 5, 10, AND 16 MCG D/, Blood, 86(10), 1995, pp. 2465-2465

Authors: GELLER RB TARANTOLO S POWELL BL KALAYCIOGLU M ZAKNOEN S KLEIN L GARRISON L
Citation: Rb. Geller et al., PHASE-II STUDY OF PIXY321 IN ELDERLY PATIENTS (PTS) WITH NEWLY-DIAGNOSED ACUTE MYELOCYTIC-LEUKEMIA (AML), Blood, 86(10), 1995, pp. 3026-3026

Authors: KALAYCIOGLU M FISHLEDER A POHLMAN B GOORMASTIC M DANNLEY R SANDS K BAUCCO P BOLWELL B
Citation: M. Kalaycioglu et al., LOWER NUMBERS OF CD 56-KILLER (NK) CELLS INFUSED AFTER SELECTIVE CD8+T-CELL DEPLETED (TCD) ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) ARE ASSOCIATED WITH IMPROVED SURVIVAL( NATURAL), Blood, 84(10), 1994, pp. 10000339-10000339

Authors: BOLWELL B KALAYCIOGLU M POHLMAN B BAUCCO P LICHTIN A ANDRESEN S GOORMASTIC M DANNLEY R VUKOVICH K FISHLEDER A
Citation: B. Bolwell et al., T-CELL DEPLETION (TCD) OF CD8-BASED PREPARATIVE REGIMENS( CELLS IS ASSOCIATED WITH AN INCREASED RISK OF GRAFT FAILURE, BUT NOT RELAPSE, IN CML USING BUSULFAN), Blood, 84(10), 1994, pp. 10000340-10000340

Authors: GEWIRTZ A KALAYCIOGLU M BOLWELL B GOORMASTIC M FISHLEDER A
Citation: A. Gewirtz et al., RETICULIN CONTENT OF RECIPIENT BONE-MARROW DOES NOT AFFECT RATE OF ENGRAFTMENT IN ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 84(10), 1994, pp. 10000487-10000487

Authors: POHLMAN B DANLEY RA KALAYCIOGLU M LICHTIN AE ANDRESEN SA BOLWELL B
Citation: B. Pohlman et al., GROWTH-FACTOR MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS ARE SUFFICIENT TO SUSTAIN LONG-TERM HEMATOPOIESIS FOLLOWING MYELOABLATIVE CHEMOTHERAPY, Blood, 84(10), 1994, pp. 10000718-10000718

Authors: BOLWELL B DANNLEY R ZGRABIK J LICHTIN A ANDRESEN S POHLMAN B TATE J GOORMASTIC M SANDS K KALAYCIOGLU M
Citation: B. Bolwell et al., ANALYSIS OF FACTORS INFLUENCING THE YIELD OF BONE-MARROW HARVEST IN THE OUT PATIENT SETTING, Blood, 84(10), 1994, pp. 10000733-10000733

Authors: KALAYCIOGLU M COPELAN E AVALOS B KLEIN J LICHTIN A ANDRESEN S FISHLEDER A TUASON L BOLWELL B
Citation: M. Kalaycioglu et al., MAJOR ABO-INCOMPATIBLE ALLOGENEIC BONE-MARROW TRANSPLANTATION AFTER TREATMENT WITH BUSULFAN AND CYCLOPHOSPHAMIDE - DECREASED RISK OF LEUKEMIC RELAPSE, Experimental hematology, 21(8), 1993, pp. 1108-1108

Authors: KALAYCIOGLU M BOLWELL B
Citation: M. Kalaycioglu et B. Bolwell, EOSINOPHILIA AFTER BUSULFAN AND CYCLOPHOSPHAMIDE FOLLOWED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 82(10), 1993, pp. 10000632-10000632
Risultati: 1-15 |